Strong Inhibitors Of Cyp2d6 has 2 known drug interactions based on U.S. FDA drug labeling data. Of these, 1 are contraindicated combinations that should be avoided entirely. Notable interactions include combinations with Triazolam, Sofpironium Bromide. Patients taking Strong Inhibitors Of Cyp2d6 should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 2
Contraindicated: 1
Moderate: 1

Contraindicated (1)

Strong Inhibitors Of Cyp2d6 + Triazolam— Concomitant use has profound effect on triazolam clearance, resulting in increased concentrations and increased risk of …

Moderate (1)

Strong Inhibitors Of Cyp2d6 + Sofpironium Bromide— Avoid co-administration of SOFDRA with drugs that are strong inhibitors of CYP2D6.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.